CN104830875A - 表达猪传染性胃肠炎病毒s蛋白a位点的重组猪痘病毒载体疫苗 - Google Patents
表达猪传染性胃肠炎病毒s蛋白a位点的重组猪痘病毒载体疫苗 Download PDFInfo
- Publication number
- CN104830875A CN104830875A CN201510172237.2A CN201510172237A CN104830875A CN 104830875 A CN104830875 A CN 104830875A CN 201510172237 A CN201510172237 A CN 201510172237A CN 104830875 A CN104830875 A CN 104830875A
- Authority
- CN
- China
- Prior art keywords
- virus
- site
- protein
- recombinant swinepox
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000282898 Sus scrofa Species 0.000 title claims abstract description 64
- 101710139375 Corneodesmosin Proteins 0.000 title claims abstract description 35
- 241000711484 Transmissible gastroenteritis virus Species 0.000 title claims abstract description 35
- 102100031673 Corneodesmosin Human genes 0.000 title claims abstract description 34
- 241000700568 Suipoxvirus Species 0.000 title abstract 6
- 229940126580 vector vaccine Drugs 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 43
- 229960005486 vaccine Drugs 0.000 claims abstract description 13
- 241000700565 Swinepox virus Species 0.000 claims description 72
- 241000700605 Viruses Species 0.000 claims description 44
- 208000005577 Gastroenteritis Diseases 0.000 claims description 27
- 239000012634 fragment Substances 0.000 claims description 23
- 208000015181 infectious disease Diseases 0.000 claims description 20
- 230000002458 infectious effect Effects 0.000 claims description 17
- 239000013605 shuttle vector Substances 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 239000002356 single layer Substances 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 9
- 108091008146 restriction endonucleases Proteins 0.000 claims description 9
- 238000013461 design Methods 0.000 claims description 7
- 238000013016 damping Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 238000012423 maintenance Methods 0.000 claims description 5
- 102000003960 Ligases Human genes 0.000 claims description 4
- 108090000364 Ligases Proteins 0.000 claims description 4
- 238000003757 reverse transcription PCR Methods 0.000 claims description 4
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 3
- 206010000496 acne Diseases 0.000 claims description 3
- 238000001502 gel electrophoresis Methods 0.000 claims description 3
- 230000006801 homologous recombination Effects 0.000 claims description 3
- 238000002744 homologous recombination Methods 0.000 claims description 3
- 238000001638 lipofection Methods 0.000 claims description 3
- 239000002502 liposome Substances 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 229940031551 inactivated vaccine Drugs 0.000 abstract description 9
- 229940031567 attenuated vaccine Drugs 0.000 abstract description 4
- 238000002649 immunization Methods 0.000 abstract description 4
- 230000003053 immunization Effects 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 241000282887 Suidae Species 0.000 abstract description 2
- 230000007918 pathogenicity Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 35
- 210000002966 serum Anatomy 0.000 description 20
- 238000012360 testing method Methods 0.000 description 17
- 101150010882 S gene Proteins 0.000 description 11
- 230000036039 immunity Effects 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 101000720130 Rattus norvegicus Acyl-coenzyme A synthetase ACSM3, mitochondrial Proteins 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 230000003472 neutralizing effect Effects 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 235000011089 carbon dioxide Nutrition 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 238000012797 qualification Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 229940096437 Protein S Drugs 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 102000004533 Endonucleases Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000029301 Protein S Human genes 0.000 description 3
- 108010066124 Protein S Proteins 0.000 description 3
- 230000010530 Virus Neutralization Effects 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000012930 cell culture fluid Substances 0.000 description 3
- 239000013553 cell monolayer Substances 0.000 description 3
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000011330 nucleic acid test Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002845 virion Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 101710198474 Spike protein Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 101000889608 Sus scrofa Aminopeptidase N Proteins 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 101150100366 end gene Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229940023832 live vector-vaccine Drugs 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229940005654 nitrite ion Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510172237.2A CN104830875B (zh) | 2015-04-13 | 2015-04-13 | 表达猪传染性胃肠炎病毒s蛋白a位点的重组猪痘病毒载体疫苗 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510172237.2A CN104830875B (zh) | 2015-04-13 | 2015-04-13 | 表达猪传染性胃肠炎病毒s蛋白a位点的重组猪痘病毒载体疫苗 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104830875A true CN104830875A (zh) | 2015-08-12 |
CN104830875B CN104830875B (zh) | 2018-08-07 |
Family
ID=53809075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510172237.2A Expired - Fee Related CN104830875B (zh) | 2015-04-13 | 2015-04-13 | 表达猪传染性胃肠炎病毒s蛋白a位点的重组猪痘病毒载体疫苗 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104830875B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110468112A (zh) * | 2019-08-07 | 2019-11-19 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 重组修饰的猪传染性胃肠炎病毒弱毒株及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198268A (zh) * | 2011-03-29 | 2011-09-28 | 范红结 | 表达马链球菌兽疫亚种类m蛋白的重组猪痘病毒载体疫苗 |
-
2015
- 2015-04-13 CN CN201510172237.2A patent/CN104830875B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198268A (zh) * | 2011-03-29 | 2011-09-28 | 范红结 | 表达马链球菌兽疫亚种类m蛋白的重组猪痘病毒载体疫苗 |
Non-Patent Citations (2)
Title |
---|
REN,X.-F ET AL: "Transmissible gastroenteritis virus isolate TH-98 S protein (S) mRNA, complete cds", 《GENBANK: AF494337.1》 * |
于天飞等: "猪传染性胃肠炎病毒S蛋白抗原位点分子特征分析", 《生物技术通报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110468112A (zh) * | 2019-08-07 | 2019-11-19 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 重组修饰的猪传染性胃肠炎病毒弱毒株及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104830875B (zh) | 2018-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104248762B (zh) | 一种猪流行性腹泻疫苗组合物及其制备方法和应用 | |
CN109439634B (zh) | 伪狂犬病病毒基因工程弱毒疫苗株及其应用 | |
CN109195623A (zh) | 嵌合型猪圆环病毒2型(pcv2)疫苗 | |
CN108653724A (zh) | 一种用于预防禽减蛋综合征的疫苗组合物、及其制备方法和应用 | |
CN108126191A (zh) | 一种疫苗组合物及其制备方法和应用 | |
TW201004972A (en) | Novel avian astrovirus | |
CN105695423B (zh) | 表达传染性法氏囊病毒vp2基因的重组鸡马立克氏病病毒疫苗株及其构建方法和应用 | |
CN109321535A (zh) | 一种热稳定的新城疫病毒弱毒疫苗候选株 | |
CN109321534A (zh) | 一种重组基因viii型新城疫病毒弱毒株 | |
CN104059889B (zh) | 伪狂犬病病毒变异株双基因缺失毒株及其构建方法和应用 | |
CN108794583B (zh) | 貉细小病毒病毒样颗粒、其制备方法与应用以及该病毒样颗粒制备的疫苗 | |
CN108653725A (zh) | 一种用于预防禽减蛋综合征的疫苗组合物、及其制备方法和应用 | |
CN111647087B (zh) | 一种嵌合病毒样颗粒疫苗及其制备方法和应用 | |
CN106939320B (zh) | 一种伪狂犬病毒js-2012株感染性克隆质粒、构建方法与应用 | |
CN108101967A (zh) | Ⅰ群血清4型禽腺病毒基因工程亚单位疫苗、制备方法及其应用 | |
AU2020103776A4 (en) | Koi herpesvirus (khv) orf-149-based carbon nanotube supported nucleic acid vaccine and application thereof | |
Yuan et al. | DNA vaccination with a gene encoding VP60 elicited protective immunity against rabbit hemorrhagic disease virus | |
CN104830875B (zh) | 表达猪传染性胃肠炎病毒s蛋白a位点的重组猪痘病毒载体疫苗 | |
CN108753739B (zh) | 表达猪瘟病毒e2蛋白的重组伪狂犬病毒毒株及其制备方法和应用 | |
CN115386556B (zh) | 一株串联表达非洲猪瘟病毒p30、p54基因重组伪狂犬病毒基因工程疫苗及其应用 | |
CN110331135A (zh) | 表达基因vii型新城疫病毒融合蛋白的重组火鸡疱疹病毒候选疫苗株及制备方法 | |
CN105132437B (zh) | 表达鼠伤寒沙门菌OmpL蛋白的重组猪痘病毒载体疫苗 | |
CN112891528B (zh) | 一种鸡传染性支气管炎疫苗株 | |
CN111647610B (zh) | 一种互换ha和ns1缺失基因包装信号的h9n2亚型禽流感病毒及其构建方法和应用 | |
Dahiya et al. | VP2 gene based phylogenetic relationship of Indian isolates of Bluetongue virus serotype 1 and other serotypes from different parts of the world |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180222 Address after: 211225 Lishui County, Nanjing City, white horse town national agricultural science and Technology Park, Nanjing Agricultural University, Applicant after: NANJING AGRICULTURAL University Applicant after: NANJING CHANGJI BIOTECHNOLOGY Co.,Ltd. Address before: 211225 Lishui County, Nanjing City, white horse town national agricultural science and Technology Park, Nanjing Agricultural University, Applicant before: Nanjing Agricultural University |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180807 |